Mukka Proteins Approves Warrants, Investments

Mukka Proteins Ltd's Board of Directors met on June 12, 2026, approving the preferential issue of up to 2 crore Fully Convertible Warrants to non-promoter entities at Rs. 23.50 per warrant, aggregating Rs. 47 crore. These warrants are convertible into equity shares within 18 months, subject to shareholder approval. The company also approved draft postal ballot notices for seeking member approval and set the e-voting period from June 13 to July 12, 2026. Additionally, the Board sanctioned investments not exceeding Rs. 11.10 crore in Delta Marine Products and Rs. 15 crore in Aqua Marine, both partnership firms.